🦠 Clostridioides difficile Infection (CDI) Treatment
UseUse to choose fidaxomicin or vancomycin for initial/recurrent CDI, taper-pulse or FMT for multiple recurrence…
SourceJohnson S, et al. IDSA/SHEA 2021 Focused Update Guidelines on Management of CDI in Adults. Clin Inf…
This-shift next steps
After scoring: open the scene pack, peer scores, and the matching pathway. Local reference — no HIS write.
Paste the link in Slack, Teams, X, or LinkedIn — the preview image comes from this page’s Open Graph card.
Methodology · worked example, guidelines & full notes
Metronidazole is no longer a first-line agent and is reserved for non-severe disease only when a preferred drug is unavailable. (original synthesis · not guideline verbatim)
When to use
Use to choose fidaxomicin or vancomycin for initial/recurrent CDI, taper-pulse or FMT for multiple recurrences, and high-dose vancomycin + IV metronidazole for fulminant disease.
How it works
Initial (non-severe/severe) → fidaxomicin or oral vancomycin ×. First recurrence → fidaxomicin or vancomycin taper-pulse. Multiple recurrences → taper-pulse/rifaximin/FMT. Fulminant → high-dose vancomycin + IV metronidazole + surgery.
Key points
- Metronidazole is no longer a first-line agent and is reserved for non-severe disease only when a preferred drug is unavailable. (original synthesis · not guideline verbatim)
- A test of cure is not performed, since asymptomatic carriage can persist.
- Bezlotoxumab may be added to reduce recurrence in high-risk patients.
References
- [Guideline / primary source]Johnson S, et al. IDSA/SHEA 2021 Focused Update Guidelines on Management of CDI in Adults. Clin Infect Dis 2021.
- [Guideline / primary source]Kelly CR, et al. ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of CDI. Am J Gastroenterol 2021.
Worked calculation
The values below come from this tool's own example placeholders and are computed server-side with the formula shown on this page, so the arithmetic can be checked quickly. It demonstrates how to substitute values only — it is not clinical advice and not a real case.
| Episode | First recurrence |
|---|---|
| Severity | Severe (criteria [Pending update]) |
→RegimenFidaxomicin/vancomycin taper-pulse
- Treatment：First recurrence: if initial was vancomycin/metronidazole → fidaxomicin, or a vancomycin tapered + pulsed regimen; if initial was fidaxomicin → vancomycin taper-pulse or repeat fidaxomicin; high-risk patients may add bezlotoxumab to reduce recurrence
- Severity：Severe (criteria [Pending update]): still use fidaxomicin or oral vancomycin, watch closely for progression to fulminant disease
- General：Stop inciting antibiotics where possible, avoid antimotility agents; metronidazole only if a first-line drug is unavailable and disease is non-severe; do not perform a test of cure
| Episode | Initial |
|---|---|
| Severity | Non-severe (criteria [Pending update]) |
→RegimenFidaxomicin or vancomycin (oral)
- Treatment：Initial (non-severe or severe): fidaxomicin(preferred, fewer recurrences) or vancomycin qid PO; both superior to metronidazole
- Severity：Non-severe (criteria [Pending update])
- General：Stop inciting antibiotics where possible, avoid antimotility agents; metronidazole only if a first-line drug is unavailable and disease is non-severe; do not perform a test of cure
Verification & sources · governance
FAQ
Frequently asked questions
- What are the limits and cautions when using Clostridioides difficile Infection (CDI) Treatment?
- For licensed clinicians and clinical researchers. Interpret results with history, investigations and local protocols; not a diagnosis or prescription, and not a substitute for multidisciplinary decision-making or local guidelines.
- Does Clostridioides difficile Infection (CDI) Treatment upload patient data? Where is it calculated?
- Calculation runs locally in the browser; inputs and results are not uploaded. For licensed clinicians only; interpret with history, investigations and local protocols — not a diagnosis or prescription.
- How is Clostridioides difficile Infection (CDI) Treatment calculated in practice? Can you show a worked example?
- Inputs: Episode First recurrence, Severity Severe (criteria [Pending update]) → Result: Regimen Fidaxomicin/vancomycin taper-pulse（Treatment: First recurrence: if initial was vancomycin/metronidazole → fidaxomicin, or a vancomycin tapered + pulsed regimen; if initial was fidaxomicin → vancomycin taper-pulse or repeat fidaxomicin; high-risk patients may add bezlotoxumab to reduce recurrence, Severity: Severe (criteria [Pending update]): still use fidaxomicin or oral vancomycin, watch closely for progression to fulminant disease, General: Stop inciting antibiotics where possible, avoid antimotility agents; metronidazole only if a first-line drug is unavailable and disease is non-severe; do not perform a test of cure） Inputs: Episode Initial, Severity Non-severe (criteria [Pending update]) → Result: Regimen Fidaxomicin or vancomycin (oral)（Treatment: Initial (non-severe or severe): fidaxomicin(preferred, fewer recurrences) or vancomycin qid PO; both superior to metronidazole, Severity: Non-severe (criteria [Pending update]), General: Stop inciting antibiotics where possible, avoid antimotility agents; metronidazole only if a first-line drug is unavailable and disease is non-severe; do not perform a test of cure）